Minnesota FOIA #N008978104

NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate...

This purchase order from the Twin Cities government agency awarded to Auckland Uniservices Ltd for a clinical research study titled 'NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622'. The contract amount is $8,873.00 USD, and it covers a single lot for the specified study. The award was made on September 13, 2023. The procurement involves a research project in the medical/clinical research sector, with no specific location details provided beyond the city Auckland, New Zealand, which is outside the US/Canada jurisdiction. The award is a direct contract for a research study, with no notable multi-year or blanket arrangement indicated.

Description

NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622